Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: Elevated expression levels of protease-activated receptors

Thrombosis and Haemostasis

Volumn 92, Issue 5, 2004, Pages 966-979

  Jesmin, Subrina ^a   Gando, Satoshi ^a   Matsuda, Naoyuki ^a   Sakuma, Ichiro ^a   Kobayashi, Shigeaki ^a   Sakuraya, Fumika ^a   Hattori, Yuichi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Activator inhibitor I; Acute lung injury; Endotoxin; Fibrin deposition; Plasminogen; Protease activated receptors; Tissue factor; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOAGULANT; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS; BLOOD VESSEL PERMEABILITY; BRONCHIOLE; BRONCHUS MUCOSA; CELL ACTIVITY; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; HEMOSTASIS; HISTOPATHOLOGY; HYPOTHESIS; IMMUNOFLUORESCENCE TEST; INFLAMMATION; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; LUNG BLOOD VESSEL; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME; TISSUE INJURY;

ANIMALS; BLOOD VESSELS; ENDOTOXINS; EPITHELIUM; KINETICS; LUNG; PLASMINOGEN ACTIVATOR INHIBITOR 1; PULMONARY ALVEOLI; PULMONARY CIRCULATION; RABBITS; RECEPTORS, PROTEINASE-ACTIVATED; RESPIRATORY DISTRESS SYNDROME, ADULT; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 9144267034     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-03-0160     Document Type: Article

References (45)

1. Cybulsky MI, Chan MKW, Movat HZ. Biology of disease: acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 1988; 58: 365-78.
2. Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C and protein S deficiencies. Chest 1992; 101: 816-23.
3. Levi M, ten Cate H, van der Poll T, et al. Pathogenesis of disseminated intravascular coagulation in sepsis. J Am Med Assoc 1993; 270: 975-9.
4. Voss R, Matthias FR, Borkowski G, et al. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990; 75: 99-105.
5. Lorente JA, Garcia-Frade LJ, Landin L, et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103: 1536-42.
6. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activator after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320: 1165-72.
7. Biemond BJ, Levi M, ten Cate H, et al. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci 1995; 88: 587-94.
8. Welty-Wolf KE, Carraway MS, Ortel TL, et al. Coagulation and inflammation in acute lung injury. Thromb Haemost 2002; 88: 17-25.
9. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31 [Suppl.]: S213-20.
10. Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-20.
11. Quax PHA, van der Hoogen CM, Verheijen JH, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J Biol Chem 1990; 265: 15560-3.
12. Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α and transforming growth factor-β. J Clin Invest 1991; 88: 1346-53.
13. Fearns C, Thinnes T, Roegner K, Loskutoff DJ. Kinetics of induction of PAI-1 gene expression on liver endothelial cells and hepatocytes by lipopolysaccharide (LPS). Thromb Haemost 1993; 69: 757a (Abstr).
14. van der Poll T, Levi M, Büller HR, et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174: 729-32.
15. Boermeester MA, van Leeuwen PA, Coyle SM, et al. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch Surg 1995; 130: 739-48.
16. Seki T, Gelehrter TD. Interleukin-1 induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression in the mouse hepatocyte line, AML 12. J Cell Physiol 1996; 168: 648-56.
17. Montes R, Rodríguez-Whilhelmi P, Hurtado V, et al. The endotoxin-induced plasminogen activator inhibitor-1 increase in rabbits is not tumor necrosis factor-α dependent and can occur in the absence of interleukin-1β. Thromb Haemost 2002; 88: 639-43.
18. Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-9.
19. Drake TA, Cheng J, Chang A, et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-70.
20. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Moll Cell Biol 1989; 9: 2752-5.
21. Crossman DC, Carr DP, Tuddenham EGD, et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-7.
22. Mackman N, Sawdey MS, Keeton MR, et al. Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993; 143: 76-84.
23. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267: L223-41.
24. sα in septic rabbits. Anesthesiology 2000; 93: 1465-73.
25. 2-receptor gene expression during endotoxemia. Naunyn-Schmiedeberg's Arch Pharmacol 2002; 366: 513-21.
26. 1-adrenoceptor mRNA expression in rat heart. Biochem Pharmacol 1999; 58: 881-5.
27. Kopp CW, Hölzenbein T, Steiner S, et al. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattration and reduced gelatinolytic activity. Blood 2004; 103: 1653-61.
28. Haranaka K, Satomi N, Sakurai A, et al. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 1985; 36: 395-400.
29. Partridge CA, Gerritsen ME. Dexamethasone increases the release of three 44 kD proteins immunologically related to plasminogen activator inhibitor-1 from human umbilical vein endothelial and rabbit coronary microvessel endothelial cells. Thromb Res 1990; 57: 139-54.
30. Huynh TTT, Davies MG, Thompson MA, et al. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. J Vasc Surg 2001; 33: 400-7.
31. Lanuza MA, Garcia N, González CM, et al. Role of expression of thrombin receptor PAR-1 in muscle cells and neuromuscular junctions during the synapse elimination period in the neonatal rat. J Neurosci Res 2003; 73: 10-21.
32. Copple BL, Moulin F, Hanumegowda UM, et al. Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers. J Pharmacol Exp Ther 2003; 305: 417-425.
33. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986; 133: 913-27.
34. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
35. Ghofrani HA, Rosseau S, Walmrath D, et al. Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. Am J Physiol 1996; 270: L62-8.
36. Kirchhofer D, Nemerson Y. Initiation of blood coagulation: the tissue factor / factor VIIa complex. Curr Opin Biotechnol 1996; 7: 386-91.
37. Hara S, Asada Y, Hatakeyama K, et al. Expression of tissue factor and tissue factor pathway inhibitor in rat lungs with lipopolysaccharide-induced disseminated intravascular coagulation. Lab Invest 1997; 77: 581-9.
38. Erlich J, Fearns C, Mathison J, et al. Lipopolysaccharide induction of tissue factor expression in rabbits. Infection Immunity 1999; 67: 2540-6.
39. Miller DL, Welty-Wolf K, Carraway MS, et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 2002; 26: 650-8.
40. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298-307.
41. Nystedts S, Ramakrishnan V, Sundelin J. The protease-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J Biol Chem 1996; 27: 14910-5.
42. Carla C, Aldo P, Mariarosaria B, et al. Protease-activated receptor-2 involvement in hypertension in normal and endotoxemic rats in vivo. Circulation 1999; 99: 2590-7.
43. Patterson C, Stouffer GA, Madamanchi N, et al. New tricks for old dogs. Nonthrombotic effects of thrombin in vessel wall in biology. Circ Res 2001; 88: 987-97.
44. O'Brien PJ, Molino M, Kahn M, et al. Protease activated receptors: theme and variations. Oncogene 2001; 20: 1570-81.
45. Derian CK, Damiano BP, D'Andrea MR, et al. Thrombin regulation of cell function through protease-activated receptors: implications for therapeutic intervention. Biochemistry (Moscow) 2002; 67: 66-76.